Anitocabtagene Autoleucel
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Anitocabtagene Autoleucel, covering 2025-08-01 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma [Phase 3]